Andrew D Meyer, M.D., M.S., C.TS., FAAP

Currently seeking M.S. & Ph.D. students.

A physician-scientist who integrates biomedical engineering and medical research to improve the lives of critically ill children. 

• Professional Background

  Education

  • 2016 - Certificate - Translational Science - UT Health - San Antonio
  • 2004 - MD - Medicine - Virginia Commonwealth University School of Medicine
  • 2000 - MS - Biomedical Engineering - Virginia Commonwealth University/MCV Campus
  • 1997 - BS - Nuclear Engineering/Material Science & Eng. - University of California at Berkeley

  Training

  • 2011 - Fellowship in Critical Care - Pediatric Critical Care - Children's National Medical Center
  • 2008 - Residency - Internal Medicine and Pediatrics - Virginia Commonwealth University Health
  • 2005 - Internship - Internal Medicine and Pediatrics - Virginia Commonwealth University Health

  Appointments

  • 9/2020 - Associate Professor with Tenure of Pediatrics - UT Health San Antonio, Pediatrics, San Antonio
  • 1/2014 - Research Physician - US Army Institute for Surgical Research, Blood and Coagulation Division, San Antonio
  • 12/2011 - Adjunct Associate Professor - UTSA/UTHSCSA Joint Graduate Program in Biomedical Engineering, Biomedical Engineering, San Antonio
  • 8/2011 - Physician - University Hospital, Pediatrics, San Antonio
  • 8/2011 - Assistant Professor of Pediatric Critical Care - UT Health, Pediatrics, San Antonio

• Instruction & Training

  • 1/2019 - Present, Post Graduate Rotation Supervision, UT Health San Antonio
  • 3/2018 - Present, Post Graduate Rotation Supervision, UT-Health San Antonio
  • 8/2017 - Present, Individual Instruction, UT Health San Antonio - Senior Research Assistant
  • 8/2017 - Present, Membership on Supervising Committee, UTHSCSA-UTSA Biomedical Engineering Joint Graduate Program in Biomedical Engineering
  • 8/2017 - Present, Individual Instruction, UT Health-San Antonio
  • 8/2017 - Present, Individual Instruction, UT-Health San Antonio
  • 8/2015 - Present, Membership on Supervising Committee, UTHSCSA-Department of Pharmacology Physiology
  • 8/2013 - Present, Membership on Supervising Committee, UTHSCSA
  • 9/2011 - Present, University Hospital PICU Medical Service, University Hospital
  • 9/2011 - Present, Division of Pediatric Critical Care Fellowship Conferences, UTHSCSA
  • 8/2011 - Present, Membership on Supervising Committee, UTHSCSA

• Research & Grants

  Coagulopathy of Extracorporeal Membrane Oxygenation (ECMO) Systems: ECMO can be a life-saving, yet coagulation complications are common causing significant morbidty and loss of limb. Our goal is to develop methods and assays to safely decrease these complications. Coagulopathy in Pediatric, Congenital, or Diseased Populations:  Current laboratory tests are poor predictors, novel methods may identify coagulopathy in chromosomal abnormalities, cystic fibrosis, oncology, diabetes, or COVID-19. TEAPOT: Tranexamic acid Atomized for Pediatric post-Operative Tonsillectomy hemorrage, a large multicenter trial to reduce this deadly complication.

  Meyer Lab

  Research profile

  Grants

  • Contact Pathway Activation on Vascular Devices
  • Pro-thrombotic Microparticles Generated by Pediatric Cardiopulmonary Bypass
  • Coagulation Complications of CardioPulmOnary Bypass

  Federal

  Funding Agency National Heart Lung and Blood Institute Title Contact Pathway Activation in Vascular Devices Status Active Period 7/2018 - 6/2023 Role Principal Investigator Grant Detail The goal of the project is to define the therapeutic potential of targeting contact activation to prevent vascular device-related thrombosis using in vitro, ex vivo and in vivo models of vascular devices. Funding Agency NIH Division of Loan Repayment 1st Renewal Title Platelet-derived microparticles generated by pediatric cardiopulmonary bypass As a novel biomarker of post-operative patient outcomes Status Active Period 7/2018 - 6/2020 Role Principal Investigator Grant Detail To reduce Dr. Meyer medical student loan debt to continue pediatric research Funding Agency DOD/CCCRP-Task Area: B-Coagulation & Blood Research @ USAISR Title Define optimal operating parameters for extracorporeal support in a clinically relevant in vitro ECMO model using human blood Status Active Period 10/2016 - 9/2019 Role Co-Investigator Grant Detail Combat Causality Research Program with Army Medicine. Accepted for funding but funds not available. Received a very competitive score of 1.9/5 Funding Agency DOD/CCCRP-Task Area: B-Coagulation & Blood Research @ USAISR Title Define the interaction of anti-coagulants and cell-based therapies with biomaterial surfaces in a laboratory ECMO model using human blood Status Active Period 10/2016 - 9/2019 Role Co-Investigator Grant Detail CCombat Causality Research Program with Army Medicine. Accepted for funding but funds not available. Received a very competitive score of 2.2/5 Funding Agency NIH/NHLBI Title Pro-thrombotic Microparticles Generated by Pediatric Cardiopulmonary Bypass Status Active Period 8/2015 - 4/2019 Role Principal Investigator Grant Detail The goal of this award is to provide the PI protected time and career development to define how pump-produced PMPs and MoMPs contribute to thrombosis, from a pediatric model of CPB and from pediatric patients supported by CPB, to understand the mechanisms and subsequent therapeutics to address extracorporeal blood pump related thrombotic complications. Funding Agency NIH Division of Loan Repayment Title Platelet-derived microparticles generated by pediatric cardiopulmonary bypass as a Novel biomarker of post-operative patient outcomes Status Complete Period 7/2016 - 6/2018 Role Co-Investigator Grant Detail To reduce Dr. Meyer medical student loan debt to continue pediatric research.

  Private

  Funding Agency STAGO Title Utility of ProCoag PPL in predicting thrombin generation and clot formation in CPB Status Complete Period 1/2017 - 12/2020 Role Principal Investigator Grant Detail The goal of this materials transfer agreement is to establish the clinical relevance of STAGO
  Procoag PPL cloting test Funding Agency Jaeb Center for Health Research, INC. Title PREvelance of pediatric DIabetes CoagulopaThy (PREDICT STUDY) Status Active Period 4/2018 - 3/2020 Role Co-Principal Investigator Grant Detail To identify early markers for thromboembolism in diabetic-related cardiovascular and cerebrovascular mortality in T1DM and T2DM youth. Funding Agency Halyard Sales, LLC Title A randomized controlled trial for optimal feeding tube placement Status Active Period 12/2017 - 11/2019 Role Principal Investigator Grant Detail A randomized controlled trial for optimal feeding tube placement
  Goal: To perform a randomized controlled trial to define if using Halyard Cortrak system compared to standard blind technique reduces time, complications, and radiographs associated with nasojejunal tube placement in pediatric patients. Funding Agency American Heart Association Title Coagulation Complications of Cardiopulmonary Bypass (C-3PO Study) Status Active Period 7/2016 - 6/2018 Role Principal Investigator Grant Detail The goal of this award is to define the generation and clearance of pro-thrombotic platelet-derived microparticles in adults and children supported with cardiopulmonary bypass.

  State

  Funding Agency School of Medicine Title Department of Pediatrics Faculty Start-Up Funds Status Active Period 9/2011 - 9/2018 Role Principal Investigator Grant Detail Allowed purchase of necessary equipment to establish the functionality of the research laboratory with both routine(e.g. refrigerator, pH meter, balance, pipettes) and specialized equipment (refrigerated centrifuge, -80 degree freezer, roller and centrifugal pumps), respectively

   

  Funding Agency DOD/CCRP -Task Area B-Coagulation & Blood Research at USAISR Title Evaluation of the platelet protein, mRNA, and mitochondria DNA signatures generated in an in vitro model of ECMO using human blood Status Active Period 10/2016 - 9/2019 Role Co-Investigator Grant Detail Combat Causality Research Program with Army Medicine. Accepted for funding but funds not available. Received a very competitive score of 2.1/5 Funding Agency UTHSCSA CTSA-IIMS Title EMILIN2 genetic variation effects on platelet aggregation and thrombosis Status Complete Period 1/2016 - 9/2017 Role Principal Investigator Grant Detail The goal of this award is to define in the laboratory and in the clinic the overall hypothesis that EMILIN2 gene copy number will change the phenotype of platelet aggregation. Identification of this gene in humans will lead to new diagnostic and therapeutic interventions

• Service

  Department

  Active physician in the Pediatric Congenital Cardiac Care Unit at University Hospital. I also serve as lead of the Quality Improvement meetings to decrease noise, delirium, and sedation projects in the pediatrics intensive care units, floors, and nurseries.

   

  School

  During my service week, I actively teach third- and fourth-year medical students, second- and third-year pediatric residents, nurse practioners, physician assistants, and fellows. I have been an AHA Pediatric Advanced Life Support instructor since 2014 teaching several classes every year to certify the public, respiratory therapists, pharmacists, nurses, residents, and physicians to provide lifesaving pediatric care.

  Institutional

  Locally, I served on the grant committees such as the IIMS Translational Science Training TL1 Program, IIMS and School of Medicine Pilot Projects, posters for the San Antonio Post-doctoral Research Forum, and Medical Student Research Day. I serve as a member of the UTHSCA Institutional Review Board with specific expertise in pediatric studies. Lastly, I am the longest serving member on University Hospital Research Committee serving as chair several times a year

  National Service

  Peer reviewer for the ASAIO, Transfusion, and AJRCC, and Thrombosis Research. I am on the editorially board of  Journal of Extracorporeal Technoogy (JECT). My national grant review service includes the  NICHD Special Committee on Small Business Research Grants (SBIR) in Pediatrics, NIH CSR  on Pediatric, Endocrine, and Reproductive SBIR (R43/R44), Congressional Directed Medical Research Programs (CDMRP), and the American Heart Association.

  Community Service

  Cubmaster of Pack 59 at Alamo Heights Methodist Church, I also practice pottery at the Southwest School of Art. I am happily married with two children.

• Publications

  • NCBI List of Publications

  Electronic/Web Publication

  Meyer A. Dr. Is In: Finding a creative outlet 2017 Jun. Available from: http://www.ksat.com/sa-live/dr-is-in-finding-a-creative-outlet SAN ANTONIO - Dr. Andrew Meyer, a pediatrician with UT Health, started learning the art of pottery 15 years ago.

  Meyer A. A Center of Excellence for Children With Heart Problems Opens Its Doors 2017 Feb. Available from: http://sanantonio.mdnews.com/center-excellence-children-heart-problems-o... .

  Meyer A. PED Talks: improving Critical Care Devices 2014 May. Available from: https://www.youtube.com/watch?v=3el7Xm1GDHg&index=3&list=PLUL2lJoBjnOnRW... .

• Clinical

  Board Certifications

  • 2012 - American Board of Pediatrics/Critical Care Medicine
  • 2010 - American Board of Pediatrics

Related media